SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950162-06-000812
Filing Date
2006-07-24
Accepted
2006-07-24 15:17:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFIANTE-REGENERX - SCHEDULE 13D/A NO. 7 - 07/24/06 defiante13dano7_072406.htm SC 13D/A 171447
  Complete submission text file 0000950162-06-000812.txt   173467
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Subject) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-37889 | Film No.: 06976482
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUA DOS FERREIROS,260 FUNCHAL MADEIRA S1 9000-082
Business Address
DEFIANTE FARMACEUTICA LDA (Filed by) CIK: 0001168857 (see all company filings)

Type: SC 13D/A